Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis

Pediatric Nephrology

Volumn 23, Issue 1, 2008, Pages 19-25

  Fusshoeller, Andreas ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aquaporin 1; Encapsulating peritoneal sclerosis; Peritoneal dialysis; Peritoneal morphology; Peritoneal transport; Ultrafiltration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; ANGIOGENESIS INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; AQUAPORIN 1; CARNITINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; ICODEXTRIN; PERITONEAL DIALYSIS FLUID; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1 ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; CLINICAL TRIAL; ENCAPSULATING PERITONEAL SCLEROSIS; FIBROSIS; GENE TRANSFER; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LONG TERM CARE; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCLEROSIS; TREATMENT FAILURE; ULTRAFILTRATION; UREMIA; VASCULAR DISEASE;

AQUAPORIN 1; HUMANS; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; SCLEROSIS;

EID: 37049016466     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0541-z     Document Type: Review

References (44)

1. Rippe B, Stelin G, Haraldsson B (1991) Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40:315-325
2. Schoenicke G, Diamant R, Donner A, Roehrborn A, Grabensee B, Plum J (2004) Histochemical distribution and expression of aquaporin 1 in the peritoneum of patients undergoing peritoneal dialysis: Relation to peritoneal transport. Am J Kidney Dis 44:146-154
3. Bouts AH, Davin JC, Groothoff JW, Van Amstel SP, Zweers MM, Krediet RT (2000) Standard peritoneal permeability analysis in children. J Am Soc Nephrol 11:943-950
4. Rusthoven E, Krediet RT, Willems HL, Monnens LA, Schroder CH (2005) Sodium sieving in children. Perit Dial Int 25 [Suppl 3]:S141-S142
5. Smit W (2006) Estimates of peritoneal membrane function - new insights. Nephrol Dial Transplant 21 [Suppl 2]:S16-S19
6. Mortier S, De Vriese AS, Lameire N (2003) Recent concepts in the molecular biology of the peritoneal membrane - implications for more biocompatible dialysis solutions. Blood Purif 21:14-23
7. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479
8. Plum J, Hermann S, Fussholler A, Schoenicke G, Donner A, Rohrborn A, Grabensee B (2001) Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 78:S42-S47
9. Combet S, Ferrier ML, Van Landschoot M, Stoenoiu M, Moulin P, Miyata T, Lameire N, Devuyst O (2001) Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 12:2146-2157
10. Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD (1996) Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int 56:S17-S21
11. Albrektsen GE, Wideroe TE, Nilsen TI, Romundstad P, Radtke M, Hallan S, Aasarod K, Oien C, Laegreid IK (2004) Transperitoneal water transport before, during, and after episodes with infectious peritonitis in patients treated with CAPD. Am J Kidney Dis 43:485-491
12. Johnson DW, Agar J, Collins J, Disney A, Harris DC, Ibels L, Irish A, Saltissi D, Suranyi M (2003) Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology 8:1-7
13. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI (1999) Impact of peritoneal membrane function on long-term clinical outcome in peritoneal dialysis patients. Perit Dial Int 19 [Suppl 2]:S91-S94
14. Goffin E, Devuyst O (2006) Phenotype and genotype: Perspectives for peritoneal dialysis patients. Nephrol Dial Transplant 21:3018-3022
15. Dobbie JW, Zaki M, Wilson L (1981) Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 26:213-223
16. Smit W, Schouten N, van den Berg N, Langedijk MJ, Struijk DG, Krediet RT; The Netherlands Ultrafiltration Failure Study Group (2004) Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: A cross-sectional study. Perit Dial Int 24:562-570
17. Fussholler A, zur Nieden S, Grabensee B, Plum J (2002) Peritoneal fluid and solute transport: Influence of treatment time, peritoneal dialysis modality, and peritonitis incidence. J Am Soc Nephrol 13:1055-1060
18. Davies SJ (2004) Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int 66:2437-2445
19. Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, Plum J, Rodrigues A, Selgas R, Struijk D, Verger C; EBPG Expert Group on Peritoneal Dialysis (2005) European best practice guidelines for peritoneal dialysis. 7. Adequacy of peritoneal dialysis. Nephrol Dial Transplant 20 [Suppl 9]:S24-S27
20. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG (2006) Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17:2591-2598
21. Rumpsfeld M, McDonald SP, Johnson DW (2006) Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17:271-278
22. Sitter T, Sauter M (2005) Impact of glucose in peritoneal dialysis: saint or sinner? Perit Dial Int 25:415-425
23. Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, Jeon JS, Ha H, Lee HB (2006) Oxidative stress during peritoneal dialysis: Implications in functional and structural changes in the membrane. Kidney Int 69:2022-2028
24. Selgas R, Bajo A, Jimenez-Heffernan JA, Sanchez-Tomero JA, Del Peso G, Aguilera A, Lopez-Cabrera M (2006) Epithelial-to-mesenchymal transition of the mesothelial cell - its role in the response of the peritoneum to dialysis. Nephrol Dial Transplant 21 [Suppl 2]:S2-S7
25. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gauldie J (2002) Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728
26. Szeto CC, Wong TY, Lai KB, Chow KM, Li PK (2002) The role of vascular endothelial growth factor in peritoneal hyperpermeability during CAPD-related peritonitis. Perit Dial Int 22:265-267
27. Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O (2000) Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717-728
28. Davies SJ, Brown EA, Frandsen NE, Rodrigues AS, Rodriguez-Carmona A, Vychytil A, Macnamara E, Ekstrand A, Tranaeus A, Filho JC; EAPOS Group (2005) Longitudinal membrane function in functionally anuric patients treated with APD: Data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 67:1609-1615
29. Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F (2003) Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 14:2632-2638
30. Fusshoeller A, Plail M, Grabensee B, Plum J (2004) Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: A prospective, randomized study. Nephrol Dial Transplant 19(8):2101-2106
31. Lee HY, Choi HY, Park HC, Seo BJ, Do JY, Yun SR, Song HY, Kim YH, Kim YL, Kim DJ, Kim YS, Kim MJ, Shin SK (2006) Changing prescribing practice in CAPD patients in Korea: Increased utilization of low GDP solutions improves patient outcome. Nephrol Dial Transplant 21:2893-2899
32. Parikova A, Smit W, Struijk DG, Krediet RT (2006) Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 70:1988-1994
33. Goffin E, Combet S, Jamar F, Cosyns JP, Devuyst O (1999) Expression of aquaporin-1 in a long-term peritoneal dialysis patient with impaired transcellular water transport. Am J Kidney Dis 33:383-388
34. Fusshoeller A, Tiemann B, Grabensee B (2006) Aquaporin 1 in the peritoneal dialysis effluent - correlation with peritoneal transport and clinical data (abstract presentation at the 37th Congress of the German Society for Nephrology)
35. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand JL, Lameire N, Devuyst O (1999) Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 10:2185-2196
36. Smit W, van den Berg N, Schouten N, Aikens E, Struijk DG, Krediet RT (2004) Free-water transport in fast transport status: A comparison between CAPD peritonitis and long-term PD. Kidney Int 65:298-303
37. Kawaguchi Y, Saito A, Kawanishi H, Nakayama M, Miyazaki M, Nakamoto H, Tranaeus A (2005) Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: Diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 25 [Suppl 4]:S83-S95
38. Hirahara I, Kusano E, Yanagiba S, Miyata Y, Ando Y, Muto S, Asano Y (2006) Peritoneal injury by methylglyoxal in peritoneal dialysis. Perit Dial Int 26:380-392
39. Numata M, Nakayama M, Hosoya T, Hoff CM, Holmes CJ, Schalling M, Nordfors L, Lindholm B (2004) Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol 62:455-460
40. Flessner MF (2006) Peritoneal ultrafiltration: Mechanisms and measures. Contrib Nephrol 150:28-36
41. Michels WM, Zweers MM, Smit W, Korevaar J, Struijk DG, van Westrhenen R, Krediet RT (2004) Does lymphatic absorption change with the duration of peritoneal dialysis? Perit Dial Int 24:347-352
42. Mortier S, Faict D, Lameire NH, De Vriese AS (2005) Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int 67:1559-1565
43. Gaggiotti E, Arduini A, Bonomini M, Valentini G, Sacchi G, Sansoni E, Salvo D, Di Paolo N (2005) Prevention of peritoneal sclerosis: A new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits). Int J Artif Organs 28:177-187
44. Kolesnyk I, Dekker F, Struijk D, Krediet R (2006) The impact of ACE inhibitors and A II receptor blockers on the peritoneal membrane function in long-term PD patients. Perit Dial Int 26 [Suppl 2]:S7 (abstract)